SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-20-002587
Filing Date
2020-05-26
Accepted
2020-05-26 07:01:22
Documents
19
Period of Report
2020-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6277
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 8517
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 460155
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 12114
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6386
6 GRAPHIC exhibit99-1x001.jpg GRAPHIC 11801
7 GRAPHIC exhibit99-1x002.jpg GRAPHIC 11801
8 GRAPHIC exhibit99-1xu001.jpg GRAPHIC 10647
9 GRAPHIC exhibit99-1xu002.jpg GRAPHIC 10516
10 GRAPHIC exhibit99-1xu003.jpg GRAPHIC 54757
11 GRAPHIC exhibit99-2x001.jpg GRAPHIC 2652
12 GRAPHIC exhibit99-3x004.jpg GRAPHIC 665
13 GRAPHIC exhibit99-3x007.jpg GRAPHIC 671
14 GRAPHIC exhibit99-3xu001.jpg GRAPHIC 3556
15 GRAPHIC exhibit99-3xu002.jpg GRAPHIC 2221
16 GRAPHIC exhibit99-4xu001.jpg GRAPHIC 2301
17 GRAPHIC exhibit99-4xu002.jpg GRAPHIC 6213
18 GRAPHIC exhibit99-4xu003.jpg GRAPHIC 27056
19 GRAPHIC exhibit99-4xu004.jpg GRAPHIC 144765
  Complete submission text file 0001062993-20-002587.txt   895392
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 20908079
SIC: 2834 Pharmaceutical Preparations